InnovoTEX Inc. — SEC Form D Filing
InnovoTEX Inc. filed an SEC Form D on August 6, 2026, reporting $750K raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 6, 2026
- Amount reported
- $750K
- Round stage
- Seed
- Industry
- Pharmaceuticals
- Website
- https://innovotex.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Pharmaceutical companies struggle with inefficient and costly textile-based manufacturing processes that can compromise product quality and safety.
Solution
InnovoTEX Inc. provides advanced, innovative textile-based materials and solutions specifically engineered to optimize pharmaceutical manufacturing, ensuring higher quality and reduced operational costs.
Why now
The specific timing catalyst is unclear from available information.
Source: SEC EDGAR Form D filing